ribosomal protein S26 pseudogene 22 (RPS26P22)

Ribosomal protein S26 pseudogene 22 (RPS26P22) is a processed pseudogene in the human genome corresponding to the parental ribosomal protein S26 gene (RPS26). Pseudogenes are non-functional sequences that arise from protein-coding genes but have lost their protein-coding ability and do not produce functional proteins. RPS26P22 is one of many RPS26 pseudogenes dispersed throughout the genome. These pseudogenes are not known to be involved in disease, are not therapeutic targets, and have no reported biological or pharmacological functions[9][1][5][7]. Key facts supporting this assessment: - RPS26P22 is explicitly identified as a pseudogene in gene/protein catalogs and scientific search tools[9][1]. - By definition, pseudogenes lack protein-coding capacity and are not drug or therapeutic targets. - Parent gene RPS26 encodes a ribosomal protein involved in ribosome function and linked to Diamond-Blackfan anemia, but pseudogenes like RPS26P22 are not implicated in disease or cellular function[7][5]. - Standard drug target resources do not list pseudogenes as molecular targets. Summary: RPS26P22 is a non-coding pseudogene and is not considered a therapeutic target, does not encode a protein, has no documented biological function or role in disease, and is not associated with any drugs or therapeutic mechanisms[9][1][5][7].

Other names

RPS26_8_399RPS26P22

None